Sharp

Sharp is a contract pharmaceutical services company that provides a wide range of clinical and commercial packaging solutions. Their clinical services include pharmaceutical product development, contract manufacturing, analytical services, comparator drug supply, primary and secondary packaging, labeling, clinical trials storage and distribution, and direct-to-patient solutions. For commercial packaging, they offer services such as blisters, bottles, injectables, vial labeling and packaging, autoinjector and pen assembly, pre-filled syringe assembly, YpsoMate® device assembly, small scale sterile fill-finish, oral thin film and transdermal patches, pouches and sachets, kitting, gene therapy commercial packaging, design services, serialization, and aggregation. Sharp operates facilities in the United States, United Kingdom, Belgium, and the Netherlands, and has recently acquired Berkshire Sterile Manufacturing to enhance its capabilities in sterile injectable products. The company is committed to sustainability, participating in the Science Based Targets initiative (SBTi) to reduce greenhouse gas emissions. Sharp’s network of GMP facilities ensures global reach, production scalability, and risk mitigation. They provide integrated clinical trial supply services and commercial packaging solutions, with recent investments in gene therapy packaging and distribution capacity at their EU Heerenveen facility. Sharp has a history spanning more than 70 years in clinical supply chain services and contract pharmaceutical packaging, partnering with pharmaceutical and biotechnology clients from phase I trials through to commercial launch and lifecycle management. They offer project management, engineering services, and have a dedicated launch team for packaging services. Additionally, Sharp provides EU and UK Qualified Person Services and supports UNICEF and other community initiatives.